APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Parenteral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchParenteral Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Drugs Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Parenteral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Drugs Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Drugs Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Parenteral Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Parenteral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parenteral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Parenteral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Parenteral Drugs include Albert David, Aspen Holdings, AXA Parenterals Ltd, BAG Healthcare, Baxter Healthcare Corporation, Beximco Pharma, BML Parenteral Drugs, Cook Pharmica and Ostuka Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Parenteral Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parenteral Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parenteral Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Parenteral Drugs Segment by Company

Albert David

Aspen Holdings

AXA Parenterals Ltd

BAG Healthcare

Baxter Healthcare Corporation

Beximco Pharma

BML Parenteral Drugs

Cook Pharmica

Ostuka Pharmaceutical

Ozon Pharmaceuticals Ltd

Patheon

PSI Ltd

Southwest Pharmaceutical

B. Braun

Cisen

Fresenius

Pfizer (Hospira)

Kelun Pharma

Acebright

SSY Group

Teva Pharmaceutical Industries

Abbott

Parenteral Drugs Segment by Type

LVP Drug

SVP Drug

Parenteral Drugs Segment by Application

Hospitals

Medical Centers

Others

Parenteral Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Parenteral Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Parenteral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Parenteral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Parenteral Drugs Industry Trends Table 2. Parenteral Drugs Industry Drivers Table 3. Parenteral Drugs Industry Opportunities and Challenges Table 4. Parenteral Drugs Industry Restraints Table 5. Global Parenteral Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Parenteral Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Parenteral Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Parenteral Drugs Sales Market Share by Manufacturers Table 9. Global Parenteral Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Parenteral Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Parenteral Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Parenteral Drugs Manufacturers, Product Type & Application Table 13. Global Parenteral Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Parenteral Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of LVP Drug Table 17. Major Manufacturers of SVP Drug Table 18. Global Parenteral Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Parenteral Drugs Sales by Type (2021-2026) & (k units) Table 20. Global Parenteral Drugs Sales by Type (2027-2032) & (k units) Table 21. Global Parenteral Drugs Sales Market Share by Type (2021-2026) Table 22. Global Parenteral Drugs Sales Market Share by Type (2027-2032) Table 23. Global Parenteral Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Parenteral Drugs Revenue by Type (2021-2026) & (k units) Table 25. Global Parenteral Drugs Revenue by Type (2027-2032) & (k units) Table 26. Global Parenteral Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Parenteral Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Medical Centers Table 30. Major Manufacturers of Others Table 31. Global Parenteral Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Parenteral Drugs Sales by Application (2021-2026) & (k units) Table 33. Global Parenteral Drugs Sales by Application (2027-2032) & (k units) Table 34. Global Parenteral Drugs Sales Market Share by Application (2021-2026) Table 35. Global Parenteral Drugs Sales Market Share by Application (2027-2032) Table 36. Global Parenteral Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Parenteral Drugs Revenue by Application (2021-2026) & (k units) Table 38. Global Parenteral Drugs Revenue by Application (2027-2032) & (k units) Table 39. Global Parenteral Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Parenteral Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Parenteral Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Parenteral Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Parenteral Drugs Sales Market Share by Region (2021-2026) Table 44. Global Parenteral Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Parenteral Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 48. North America Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 49. Europe Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 51. Europe Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Parenteral Drugs Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Parenteral Drugs Sales by Country (2027-2032) & (k units) Table 58. Global Parenteral Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Parenteral Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Parenteral Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Parenteral Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Parenteral Drugs Revenue Market Share by Region (2027-2032) Table 63. Albert David Company Information Table 64. Albert David Business Overview Table 65. Albert David Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Albert David Parenteral Drugs Product Portfolio Table 67. Albert David Recent Development Table 68. Aspen Holdings Company Information Table 69. Aspen Holdings Business Overview Table 70. Aspen Holdings Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aspen Holdings Parenteral Drugs Product Portfolio Table 72. Aspen Holdings Recent Development Table 73. AXA Parenterals Ltd Company Information Table 74. AXA Parenterals Ltd Business Overview Table 75. AXA Parenterals Ltd Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AXA Parenterals Ltd Parenteral Drugs Product Portfolio Table 77. AXA Parenterals Ltd Recent Development Table 78. BAG Healthcare Company Information Table 79. BAG Healthcare Business Overview Table 80. BAG Healthcare Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BAG Healthcare Parenteral Drugs Product Portfolio Table 82. BAG Healthcare Recent Development Table 83. Baxter Healthcare Corporation Company Information Table 84. Baxter Healthcare Corporation Business Overview Table 85. Baxter Healthcare Corporation Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Baxter Healthcare Corporation Parenteral Drugs Product Portfolio Table 87. Baxter Healthcare Corporation Recent Development Table 88. Beximco Pharma Company Information Table 89. Beximco Pharma Business Overview Table 90. Beximco Pharma Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Beximco Pharma Parenteral Drugs Product Portfolio Table 92. Beximco Pharma Recent Development Table 93. BML Parenteral Drugs Company Information Table 94. BML Parenteral Drugs Business Overview Table 95. BML Parenteral Drugs Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. BML Parenteral Drugs Parenteral Drugs Product Portfolio Table 97. BML Parenteral Drugs Recent Development Table 98. Cook Pharmica Company Information Table 99. Cook Pharmica Business Overview Table 100. Cook Pharmica Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Cook Pharmica Parenteral Drugs Product Portfolio Table 102. Cook Pharmica Recent Development Table 103. Ostuka Pharmaceutical Company Information Table 104. Ostuka Pharmaceutical Business Overview Table 105. Ostuka Pharmaceutical Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Ostuka Pharmaceutical Parenteral Drugs Product Portfolio Table 107. Ostuka Pharmaceutical Recent Development Table 108. Ozon Pharmaceuticals Ltd Company Information Table 109. Ozon Pharmaceuticals Ltd Business Overview Table 110. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio Table 112. Ozon Pharmaceuticals Ltd Recent Development Table 113. Patheon Company Information Table 114. Patheon Business Overview Table 115. Patheon Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Patheon Parenteral Drugs Product Portfolio Table 117. Patheon Recent Development Table 118. PSI Ltd Company Information Table 119. PSI Ltd Business Overview Table 120. PSI Ltd Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. PSI Ltd Parenteral Drugs Product Portfolio Table 122. PSI Ltd Recent Development Table 123. Southwest Pharmaceutical Company Information Table 124. Southwest Pharmaceutical Business Overview Table 125. Southwest Pharmaceutical Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Southwest Pharmaceutical Parenteral Drugs Product Portfolio Table 127. Southwest Pharmaceutical Recent Development Table 128. B. Braun Company Information Table 129. B. Braun Business Overview Table 130. B. Braun Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. B. Braun Parenteral Drugs Product Portfolio Table 132. B. Braun Recent Development Table 133. Cisen Company Information Table 134. Cisen Business Overview Table 135. Cisen Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Cisen Parenteral Drugs Product Portfolio Table 137. Cisen Recent Development Table 138. Fresenius Company Information Table 139. Fresenius Business Overview Table 140. Fresenius Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Fresenius Parenteral Drugs Product Portfolio Table 142. Fresenius Recent Development Table 143. Pfizer (Hospira) Company Information Table 144. Pfizer (Hospira) Business Overview Table 145. Pfizer (Hospira) Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Pfizer (Hospira) Parenteral Drugs Product Portfolio Table 147. Pfizer (Hospira) Recent Development Table 148. Kelun Pharma Company Information Table 149. Kelun Pharma Business Overview Table 150. Kelun Pharma Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Kelun Pharma Parenteral Drugs Product Portfolio Table 152. Kelun Pharma Recent Development Table 153. Acebright Company Information Table 154. Acebright Business Overview Table 155. Acebright Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Acebright Parenteral Drugs Product Portfolio Table 157. Acebright Recent Development Table 158. SSY Group Company Information Table 159. SSY Group Business Overview Table 160. SSY Group Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. SSY Group Parenteral Drugs Product Portfolio Table 162. SSY Group Recent Development Table 163. Teva Pharmaceutical Industries Company Information Table 164. Teva Pharmaceutical Industries Business Overview Table 165. Teva Pharmaceutical Industries Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio Table 167. Teva Pharmaceutical Industries Recent Development Table 168. Abbott Company Information Table 169. Abbott Business Overview Table 170. Abbott Parenteral Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Abbott Parenteral Drugs Product Portfolio Table 172. Abbott Recent Development Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Parenteral Drugs Distributors List Table 176. Parenteral Drugs Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Parenteral Drugs Product Image Figure 2. Global Parenteral Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Parenteral Drugs Sales (2021-2032) & (k units) Figure 5. Global Parenteral Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Parenteral Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. LVP Drug Image Figure 9. SVP Drug Image Figure 10. Global Parenteral Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Parenteral Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Parenteral Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Parenteral Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Parenteral Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Parenteral Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Medical Centers Image Figure 18. Others Image Figure 19. Global Parenteral Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Parenteral Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Parenteral Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Parenteral Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Parenteral Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Parenteral Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 39. China Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Parenteral Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Parenteral Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Parenteral Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Parenteral Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Parenteral Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Parenteral Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Parenteral Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Parenteral Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Parenteral Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Parenteral Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • LVP Drug
  • SVP Drug
Applications
  • Hospitals
  • Medical Centers
  • Others
Companies covered
  • Albert David
  • Aspen Holdings
  • AXA Parenterals Ltd
  • BAG Healthcare
  • Baxter Healthcare Corporation
  • Beximco Pharma
  • BML Parenteral Drugs
  • Cook Pharmica
  • Ostuka Pharmaceutical
  • Ozon Pharmaceuticals Ltd
  • Patheon
  • PSI Ltd
  • Southwest Pharmaceutical
  • B. Braun
  • Cisen
  • Fresenius
  • Pfizer (Hospira)
  • Kelun Pharma
  • Acebright
  • SSY Group
  • Teva Pharmaceutical Industries
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Parenteral Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Parenteral Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Parenteral Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Parenteral Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Parenteral Drugs Market Dynamics
  1. 2.1 Parenteral Drugs Industry Trends
  2. 2.2 Parenteral Drugs Industry Drivers
  3. 2.3 Parenteral Drugs Industry Opportunities and Challenges
  4. 2.4 Parenteral Drugs Industry Restraints
3 Parenteral Drugs Market by Manufacturers
  1. 3.1 Global Parenteral Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Parenteral Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Parenteral Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Parenteral Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Parenteral Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Parenteral Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Parenteral Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Parenteral Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Parenteral Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Parenteral Drugs Tier 1, Tier 2, and Tier 3
4 Parenteral Drugs Market by Type
  1. 4.1 Parenteral Drugs Type Introduction
  2. 4.1.1 LVP Drug
  3. 4.1.2 SVP Drug
  4. 4.2 Global Parenteral Drugs Sales by Type
  5. 4.2.1 Global Parenteral Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Parenteral Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Parenteral Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Parenteral Drugs Revenue by Type
  9. 4.3.1 Global Parenteral Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Parenteral Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Parenteral Drugs Revenue Market Share by Type (2021-2032)
5 Parenteral Drugs Market by Application
  1. 5.1 Parenteral Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Medical Centers
  4. 5.1.3 Others
  5. 5.2 Global Parenteral Drugs Sales by Application
  6. 5.2.1 Global Parenteral Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Parenteral Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Parenteral Drugs Revenue by Application
  10. 5.3.1 Global Parenteral Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Parenteral Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Parenteral Drugs Revenue Market Share by Application (2021-2032)
6 Global Parenteral Drugs Sales by Region
  1. 6.1 Global Parenteral Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parenteral Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Parenteral Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Parenteral Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Parenteral Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Parenteral Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Parenteral Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Parenteral Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Parenteral Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Parenteral Drugs Revenue by Region
  1. 7.1 Global Parenteral Drugs Revenue by Region
  2. 7.1.1 Global Parenteral Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Parenteral Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Parenteral Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Parenteral Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Parenteral Drugs Revenue (2021-2032)
  8. 7.2.2 North America Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Parenteral Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Parenteral Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Parenteral Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Parenteral Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Albert David
  2. 8.1.1 Albert David Company Information
  3. 8.1.2 Albert David Business Overview
  4. 8.1.3 Albert David Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Albert David Parenteral Drugs Product Portfolio
  6. 8.1.5 Albert David Recent Developments
  7. 8.2 Aspen Holdings
  8. 8.2.1 Aspen Holdings Company Information
  9. 8.2.2 Aspen Holdings Business Overview
  10. 8.2.3 Aspen Holdings Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aspen Holdings Parenteral Drugs Product Portfolio
  12. 8.2.5 Aspen Holdings Recent Developments
  13. 8.3 AXA Parenterals Ltd
  14. 8.3.1 AXA Parenterals Ltd Company Information
  15. 8.3.2 AXA Parenterals Ltd Business Overview
  16. 8.3.3 AXA Parenterals Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AXA Parenterals Ltd Parenteral Drugs Product Portfolio
  18. 8.3.5 AXA Parenterals Ltd Recent Developments
  19. 8.4 BAG Healthcare
  20. 8.4.1 BAG Healthcare Company Information
  21. 8.4.2 BAG Healthcare Business Overview
  22. 8.4.3 BAG Healthcare Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BAG Healthcare Parenteral Drugs Product Portfolio
  24. 8.4.5 BAG Healthcare Recent Developments
  25. 8.5 Baxter Healthcare Corporation
  26. 8.5.1 Baxter Healthcare Corporation Company Information
  27. 8.5.2 Baxter Healthcare Corporation Business Overview
  28. 8.5.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
  30. 8.5.5 Baxter Healthcare Corporation Recent Developments
  31. 8.6 Beximco Pharma
  32. 8.6.1 Beximco Pharma Company Information
  33. 8.6.2 Beximco Pharma Business Overview
  34. 8.6.3 Beximco Pharma Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beximco Pharma Parenteral Drugs Product Portfolio
  36. 8.6.5 Beximco Pharma Recent Developments
  37. 8.7 BML Parenteral Drugs
  38. 8.7.1 BML Parenteral Drugs Company Information
  39. 8.7.2 BML Parenteral Drugs Business Overview
  40. 8.7.3 BML Parenteral Drugs Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BML Parenteral Drugs Parenteral Drugs Product Portfolio
  42. 8.7.5 BML Parenteral Drugs Recent Developments
  43. 8.8 Cook Pharmica
  44. 8.8.1 Cook Pharmica Company Information
  45. 8.8.2 Cook Pharmica Business Overview
  46. 8.8.3 Cook Pharmica Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cook Pharmica Parenteral Drugs Product Portfolio
  48. 8.8.5 Cook Pharmica Recent Developments
  49. 8.9 Ostuka Pharmaceutical
  50. 8.9.1 Ostuka Pharmaceutical Company Information
  51. 8.9.2 Ostuka Pharmaceutical Business Overview
  52. 8.9.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
  54. 8.9.5 Ostuka Pharmaceutical Recent Developments
  55. 8.10 Ozon Pharmaceuticals Ltd
  56. 8.10.1 Ozon Pharmaceuticals Ltd Company Information
  57. 8.10.2 Ozon Pharmaceuticals Ltd Business Overview
  58. 8.10.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
  60. 8.10.5 Ozon Pharmaceuticals Ltd Recent Developments
  61. 8.11 Patheon
  62. 8.11.1 Patheon Company Information
  63. 8.11.2 Patheon Business Overview
  64. 8.11.3 Patheon Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Patheon Parenteral Drugs Product Portfolio
  66. 8.11.5 Patheon Recent Developments
  67. 8.12 PSI Ltd
  68. 8.12.1 PSI Ltd Company Information
  69. 8.12.2 PSI Ltd Business Overview
  70. 8.12.3 PSI Ltd Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PSI Ltd Parenteral Drugs Product Portfolio
  72. 8.12.5 PSI Ltd Recent Developments
  73. 8.13 Southwest Pharmaceutical
  74. 8.13.1 Southwest Pharmaceutical Company Information
  75. 8.13.2 Southwest Pharmaceutical Business Overview
  76. 8.13.3 Southwest Pharmaceutical Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Southwest Pharmaceutical Parenteral Drugs Product Portfolio
  78. 8.13.5 Southwest Pharmaceutical Recent Developments
  79. 8.14 B. Braun
  80. 8.14.1 B. Braun Company Information
  81. 8.14.2 B. Braun Business Overview
  82. 8.14.3 B. Braun Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 B. Braun Parenteral Drugs Product Portfolio
  84. 8.14.5 B. Braun Recent Developments
  85. 8.15 Cisen
  86. 8.15.1 Cisen Company Information
  87. 8.15.2 Cisen Business Overview
  88. 8.15.3 Cisen Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cisen Parenteral Drugs Product Portfolio
  90. 8.15.5 Cisen Recent Developments
  91. 8.16 Fresenius
  92. 8.16.1 Fresenius Company Information
  93. 8.16.2 Fresenius Business Overview
  94. 8.16.3 Fresenius Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Fresenius Parenteral Drugs Product Portfolio
  96. 8.16.5 Fresenius Recent Developments
  97. 8.17 Pfizer (Hospira)
  98. 8.17.1 Pfizer (Hospira) Company Information
  99. 8.17.2 Pfizer (Hospira) Business Overview
  100. 8.17.3 Pfizer (Hospira) Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pfizer (Hospira) Parenteral Drugs Product Portfolio
  102. 8.17.5 Pfizer (Hospira) Recent Developments
  103. 8.18 Kelun Pharma
  104. 8.18.1 Kelun Pharma Company Information
  105. 8.18.2 Kelun Pharma Business Overview
  106. 8.18.3 Kelun Pharma Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Kelun Pharma Parenteral Drugs Product Portfolio
  108. 8.18.5 Kelun Pharma Recent Developments
  109. 8.19 Acebright
  110. 8.19.1 Acebright Company Information
  111. 8.19.2 Acebright Business Overview
  112. 8.19.3 Acebright Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Acebright Parenteral Drugs Product Portfolio
  114. 8.19.5 Acebright Recent Developments
  115. 8.20 SSY Group
  116. 8.20.1 SSY Group Company Information
  117. 8.20.2 SSY Group Business Overview
  118. 8.20.3 SSY Group Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 SSY Group Parenteral Drugs Product Portfolio
  120. 8.20.5 SSY Group Recent Developments
  121. 8.21 Teva Pharmaceutical Industries
  122. 8.21.1 Teva Pharmaceutical Industries Company Information
  123. 8.21.2 Teva Pharmaceutical Industries Business Overview
  124. 8.21.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
  126. 8.21.5 Teva Pharmaceutical Industries Recent Developments
  127. 8.22 Abbott
  128. 8.22.1 Abbott Company Information
  129. 8.22.2 Abbott Business Overview
  130. 8.22.3 Abbott Parenteral Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Abbott Parenteral Drugs Product Portfolio
  132. 8.22.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Parenteral Drugs Value Chain Analysis
  2. 9.1.1 Parenteral Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Parenteral Drugs Production Mode & Process
  6. 9.2 Parenteral Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Parenteral Drugs Distributors
  9. 9.2.3 Parenteral Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst